These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 30138689)
61. Fenofibrate-induced acute cholestatic hepatitis. Ho CY; Kuo TH; Chen TS; Tsay SH; Chang FY; Lee SD J Chin Med Assoc; 2004 May; 67(5):245-7. PubMed ID: 15357112 [TBL] [Abstract][Full Text] [Related]
62. [Terbinafine-induced liver toxicity in the context of a SARS-CoV-2 pandemic: a case report]. Bustios Sanchez C; Sumire Umeres J; Asato Higa C; Monge Zapata V Rev Gastroenterol Peru; 2021; 41(2):107-111. PubMed ID: 34724692 [TBL] [Abstract][Full Text] [Related]
63. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis. Agca E; Akcay A; Simsek H Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001 [No Abstract] [Full Text] [Related]
64. Systematic review of severe acute liver injury caused by terbinafine. Yan J; Wang X; Chen S Int J Clin Pharm; 2014 Aug; 36(4):679-83. PubMed ID: 24986266 [TBL] [Abstract][Full Text] [Related]
70. Large dose means significant effect--dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats. Zhao Y; Ma X; Wang J; Wen R; Jia L; Zhu Y; Li R; Wang R; Li J; Wang L; Li Y; Xiao X BMC Complement Altern Med; 2015 Apr; 15():104. PubMed ID: 25889085 [TBL] [Abstract][Full Text] [Related]
71. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine. Lovell MO; Speeg KV; Havranek RD; Sharkey FE Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595 [TBL] [Abstract][Full Text] [Related]
73. Drug-Induced Liver Injury Secondary to Terbinafine Use. Brown A; Potesta M; Hameed A Cureus; 2024 Feb; 16(2):e54453. PubMed ID: 38510874 [TBL] [Abstract][Full Text] [Related]
74. 'Intrahepatic cholestatic hepatitis following diagnostic ajmaline challenge'. Mellor G; Fellows I; Williams I Europace; 2013 Mar; 15(3):314. PubMed ID: 22804909 [No Abstract] [Full Text] [Related]
75. Acute Cholestatic Liver Injury From Hydralazine Intake. Harati H; Rahmani M; Taghizadeh S Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593 [TBL] [Abstract][Full Text] [Related]
77. Antimicrobials and Antiepileptics Are the Leading Causes of Idiosyncratic Drug-induced Liver Injury in American Children. DiPaola F; Molleston JP; Gu J; Cirulli ET; Chalasani N; Barnhart H; Kleiner DE; Hoofnagle JH; Fontana RJ; J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):152-159. PubMed ID: 31169665 [TBL] [Abstract][Full Text] [Related]
78. Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments. Li F; Dong YZ; Zhang D; Zhang XM; Lin ZJ; Zhang B PLoS One; 2019; 14(5):e0216948. PubMed ID: 31141540 [TBL] [Abstract][Full Text] [Related]
79. Hepatitis associated with terbinafine treatment. Lowe G; Green C; Jennings P BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524 [No Abstract] [Full Text] [Related]
80. Terbinafine used safely in autoimmune hepatitis for treatment of tinea corporis. Ferguson JE; Prouty M BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34035031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]